Aspirin plus coumarin versus aspirin alone in the prevention of reocclusion after fibrinolysis for acute myocardial infarction: results of the Antithrombotics in the Prevention of Reocclusion In Coronary Thrombolysis (APRICOT)-2 Trial (Q28193553)

From Wikidata
Jump to navigation Jump to search
scientific article (publication date: 6 August 2002)
edit
Language Label Description Also known as
English
Aspirin plus coumarin versus aspirin alone in the prevention of reocclusion after fibrinolysis for acute myocardial infarction: results of the Antithrombotics in the Prevention of Reocclusion In Coronary Thrombolysis (APRICOT)-2 Trial
scientific article (publication date: 6 August 2002)

    Statements

    Aspirin plus coumarin versus aspirin alone in the prevention of reocclusion after fibrinolysis for acute myocardial infarction: results of the Antithrombotics in the Prevention of Reocclusion In Coronary Thrombolysis (APRICOT)-2 Trial (English)
    0 references
    Marc A Brouwer
    0 references
    Paul J P C van den Bergh
    0 references
    Wim R M Aengevaeren
    0 references
    Gerrit Veen
    0 references
    Hans E Luijten
    0 references
    Don P Hertzberger
    0 references
    Ad J van Boven
    0 references
    Ralf P J W Vromans
    0 references
    Gérard J H Uijen
    0 references
    Freek W A Verheugt
    0 references
    6 August 2002
    0 references
    0 references
    106
    0 references
    6
    0 references
    659-65
    0 references

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit